Comerica Securities’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
$210K Sell
3,980
-20,205
-84% -$1.07M 0.02% 429
2023
Q2
$1.31M Buy
24,185
+205
+0.9% +$11.1K 0.09% 200
2023
Q1
$1.2M Buy
23,980
+1,669
+7% +$83.5K 0.09% 206
2022
Q4
$1.03M Sell
22,311
-406
-2% -$18.8K 0.07% 228
2022
Q3
$880K Sell
22,717
-213
-0.9% -$8.25K 0.07% 220
2022
Q2
$855K Buy
22,930
+683
+3% +$25.5K 0.06% 241
2022
Q1
$985K Sell
22,247
-3,333
-13% -$148K 0.07% 225
2021
Q4
$1.09M Buy
25,580
+740
+3% +$31.4K 0.07% 222
2021
Q3
$1.08M Buy
24,840
+539
+2% +$23.4K 0.08% 216
2021
Q2
$1.04M Buy
24,301
+4,093
+20% +$175K 0.08% 219
2021
Q1
$781K Buy
20,208
+3,051
+18% +$118K 0.06% 248
2020
Q4
$617K Sell
17,157
-2,263
-12% -$81.4K 0.05% 265
2020
Q3
$742K Sell
19,420
-1,722
-8% -$65.8K 0.07% 223
2020
Q2
$742K Buy
21,142
+10,848
+105% +$381K 0.07% 219
2020
Q1
$336K Sell
10,294
-12,423
-55% -$405K 0.04% 296
2019
Q4
$1.03M Sell
22,717
-1,259
-5% -$56.9K 0.1% 195
2019
Q3
$976K Buy
23,976
+2,031
+9% +$82.7K 0.1% 194
2019
Q2
$943K Buy
21,945
+498
+2% +$21.4K 0.1% 193
2019
Q1
$823K Buy
21,447
+4,729
+28% +$181K 0.09% 211
2018
Q4
$591K Sell
16,718
-26
-0.2% -$919 0.08% 226
2018
Q3
$645K Buy
16,744
+2,157
+15% +$83.1K 0.08% 241
2018
Q2
$477K Buy
14,587
+154
+1% +$5.04K 0.06% 280
2018
Q1
$394K Buy
14,433
+714
+5% +$19.5K 0.05% 293
2017
Q4
$340K Buy
13,719
+571
+4% +$14.2K 0.04% 314
2017
Q3
$384K Buy
13,148
+1,670
+15% +$48.8K 0.05% 290
2017
Q2
$318K Buy
11,478
+99
+0.9% +$2.74K 0.05% 308
2017
Q1
$283K Buy
+11,379
New +$283K 0.04% 319
2015
Q3
Sell
-10,659
Closed -$189K 202
2015
Q2
$189K Buy
+10,659
New +$189K 0.05% 325